Delivery Order SPE2DB24D1201-SPE2DB25FJAXT
Award Date 12/16/24
Potential Completion Date 12/17/24
Potential Value $3.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Ozempic, a 1 mg/dose (4 mg/3 ml) pharmaceutical product, awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA). The $7,207.20 firm fixed-price delivery order has a completion date of November 27, 2024. The contract is not designated with any set-aside requirements. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This federal contract award is for the pharmaceutical product Ozempic (0.25-0.5 mg/dose pen 3ml) and was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $16,164.54 firm-fixed-price delivery order has a completion date of March 26, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award is for the delivery of the pharmaceutical product Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The $3,664.43 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- This federal contract award is for the delivery of the pharmaceutical product Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The award, valued at $9,383.58, was made to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order, with a period of performance through May 16, 2024. Amerisourcebergen holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of the pharmaceutical product Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The fixed-price delivery order, valued at $14,136.96, has an ultimate completion date of August 26, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, has been awarded numerous contracts by various defense and civilian agencies, including the DLA...
- This federal contract award, with a ceiling value of $11,015.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The award is for a delivery order to supply the pharmaceutical product Ozempic (0.25-0.5 mg/dose pen, 3 mL) to the government. It is a firm-fixed-price contract with a period of performance through July 2024. The contract is not designated as a set-aside. AmerisourceBergen, as a major pharmaceutical distributor, has been...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,010.40, is a firm-fixed-price delivery order for the pharmaceutical product Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The contract has an ultimate completion date of March 3, 2025. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,176.30 firm fixed-price delivery order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication. The contract has an ultimate completion date of August 15, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the pharmaceutical product Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $22,524.13 firm-fixed-price delivery order contract has a completion date of July 17, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, with no major subcontractors mentioned. This contract award is part of a larger Indefinite...
- This federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,120.99 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 24, 2024 and was awarded on October 23, 2024. There was no set-aside designation for this award. AmerisourceBergen holds a...